• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚感染的流行情况及分子流行病学

Prevalence and molecular epidemiology of infection in Indonesia.

作者信息

Collins D A, Gasem M H, Habibie T H, Arinton I G, Hendriyanto P, Hartana A P, Riley T V

机构信息

School of Medical & Health Sciences, Edith Cowan University, Perth, Australia.

Department of Medicine, Faculty of Medicine Diponegoro University-Dr. Kariadi Hospital, Semarang, Indonesia.

出版信息

New Microbes New Infect. 2017 May 4;18:34-37. doi: 10.1016/j.nmni.2017.04.006. eCollection 2017 Jul.

DOI:10.1016/j.nmni.2017.04.006
PMID:28603640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5453861/
Abstract

has not been studied in detail in Asia, particularly Southeast Asia. We thus performed a prevalence study across four hospitals in Central Java province, Indonesia. Stool samples were collected from patients with diarrhoea and tested by enzyme immunoassay for glutamate dehydrogenase (GDH) and toxin A/B (C DIFF QUIK CHEK COMPLETE, TechLab). Specimens were cultured and molecular typing was performed. In total, 340 samples were tested, of which 70 (20.6%) were GDH positive, with toxin detected in 19 (5.6%). Toxigenic was isolated from 37 specimens (10.9%), while a further 36 (10.6%) nontoxigenic isolates were identified. The most common strain was ribotype 017 (24.3% of 74 isolates), followed by nontoxigenic types QX 224 (9.5%), and QX 238 and QX 108 (both 8.1%). The high prevalence of highlights a need for ongoing surveillance of infection in Indonesia.

摘要

在亚洲,尤其是东南亚地区,尚未对此进行详细研究。因此,我们在印度尼西亚中爪哇省的四家医院开展了一项患病率研究。从腹泻患者中采集粪便样本,采用酶免疫分析法检测谷氨酸脱氢酶(GDH)和毒素A/B(艰难梭菌快速检测试剂盒,TechLab公司)。对样本进行培养并进行分子分型。总共检测了340份样本,其中70份(20.6%)GDH呈阳性,19份(5.6%)检测到毒素。从37份标本(10.9%)中分离出产毒菌株,另外鉴定出36份(10.6%)非产毒菌株。最常见的菌株是核糖体分型017(74株分离株中的24.3%),其次是非产毒型QX 224(9.5%),以及QX 238和QX 108(均为8.1%)。艰难梭菌的高患病率表明在印度尼西亚需要持续监测艰难梭菌感染情况。

相似文献

1
Prevalence and molecular epidemiology of infection in Indonesia.印度尼西亚感染的流行情况及分子流行病学
New Microbes New Infect. 2017 May 4;18:34-37. doi: 10.1016/j.nmni.2017.04.006. eCollection 2017 Jul.
2
Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.基于免疫胶体金渗滤法检测和产毒培养检测对艰难梭菌感染危险因素的评估。
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.00555-18. Print 2018 Dec.
3
Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.TechLab艰难梭菌快速检测试剂盒和TechLab艰难梭菌毒素A/B II检测试剂盒在粪便样本中检测艰难梭菌的性能。
Diagn Microbiol Infect Dis. 2007 Sep;59(1):33-7. doi: 10.1016/j.diagmicrobio.2007.04.018. Epub 2007 Jul 26.
4
Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.艰难梭菌感染的实验室诊断:Techlab艰难梭菌快速检测全套、Xpert艰难梭菌检测与多步骤算法方法的比较
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22135. Epub 2017 Feb 8.
5
Simultaneous Detection of Glutamate Dehydrogenase and Toxin A/B: Comparison of the C. DIFF QUIK CHEK COMPLETE and RIDASCREEN Assays.同时检测谷氨酸脱氢酶和毒素 A/B:C. DIFF QUIK CHEK COMPLETE 和 RIDASCREEN 检测方法的比较。
Ann Lab Med. 2019 Mar;39(2):214-217. doi: 10.3343/alm.2019.39.2.214.
6
Clostridium difficile infection diagnostics - evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples.艰难梭菌感染诊断——C. DIFF Quik Chek Complete检测法的评估,一种用于检测临床粪便样本中产毒素艰难梭菌的快速酶免疫测定法。
APMIS. 2016 Nov;124(11):1016-1020. doi: 10.1111/apm.12595. Epub 2016 Sep 20.
7
Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.评估抗原阳性毒素阴性酶免疫测定结果用于诊断产毒素艰难梭菌感染
J Med Invest. 2018;65(1.2):131-135. doi: 10.2152/jmi.65.131.
8
[Experience with laboratory diagnosis of Clostridium difficile].[艰难梭菌实验室诊断经验]
Klin Mikrobiol Infekc Lek. 2013 Sep;19(3):91-5.
9
Evaluation of the performance of C. DIFF QUIK CHEK COMPLETE and its usefulness in a hospital setting with a high prevalence of Clostridium difficile infection.艰难梭菌感染高流行率医院环境中C. DIFF QUIK CHEK COMPLETE检测性能及其效用评估
J Investig Med. 2017 Jan;65(1):88-92. doi: 10.1136/jim-2016-000231. Epub 2016 Sep 13.
10
Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.巴西某大学附属医院住院患者抗生素相关性腹泻中同时进行谷氨酸脱氢酶和毒素 A/B 快速免疫测定对艰难梭菌诊断和治疗的影响。
J Gastroenterol Hepatol. 2018 Feb;33(2):393-396. doi: 10.1111/jgh.13901.

引用本文的文献

1
() infection in hospitalized adult patients in Cambodia.柬埔寨住院成年患者中的()感染。
Microbiol Spectr. 2025 Apr;13(4):e0274724. doi: 10.1128/spectrum.02747-24. Epub 2025 Feb 19.
2
Best Practices in the Management of Infection in Developing Nations.发展中国家感染管理的最佳实践
Trop Med Infect Dis. 2024 Aug 19;9(8):185. doi: 10.3390/tropicalmed9080185.
3
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile.肠道微生物组在癌症中的作用:综述,特别关注结直肠肿瘤和艰难梭菌。
Clin Infect Dis. 2023 Dec 5;77(Suppl 6):S471-S478. doi: 10.1093/cid/ciad640.
4
Prevalence of Non-Toxigenic in Diarrhoea Patients and Their Clinical Characteristics.腹泻患者中非产毒型的患病率及其临床特征。
Antibiotics (Basel). 2023 Aug 24;12(9):1360. doi: 10.3390/antibiotics12091360.
5
Insights into the Evolving Epidemiology of Infection and Treatment: A Global Perspective.《感染与治疗的演变流行病学洞察:全球视角》
Antibiotics (Basel). 2023 Jul 1;12(7):1141. doi: 10.3390/antibiotics12071141.
6
Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.东南亚艰难梭菌感染的流行病学
Am J Trop Med Hyg. 2022 Aug 8;107(3):517-26. doi: 10.4269/ajtmh.21-1167.
7
Global evolutionary dynamics and resistome analysis of ribotype 017.核糖体分型017的全球进化动力学及耐药基因组分析
Microb Genom. 2022 Mar;8(3). doi: 10.1099/mgen.0.000792.
8
ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.2004 年至 2018 年,ribotypes 001 和 126 在德黑兰医疗保健环境中占主导地位:一项长达 14 年的横断面研究。
Emerg Microbes Infect. 2020 Dec;9(1):1432-1443. doi: 10.1080/22221751.2020.1780949.
9
Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.2014 年和 2015 年来自亚太地区 12 个国家的艰难梭菌分离株的抗菌药敏性。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00296-20.
10
infection in the Asia-Pacific region.亚太地区的感染情况。
Emerg Microbes Infect. 2019 Dec 24;9(1):42-52. doi: 10.1080/22221751.2019.1702480. eCollection 2020.

本文引用的文献

1
Prevalence and molecular epidemiology of infection in Thailand.泰国感染的患病率及分子流行病学
New Microbes New Infect. 2016 Oct 21;15:27-32. doi: 10.1016/j.nmni.2016.10.004. eCollection 2017 Jan.
2
Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology.艰难梭菌感染:进化、系统发育与分子流行病学
Infect Genet Evol. 2017 Apr;49:1-11. doi: 10.1016/j.meegid.2016.12.018. Epub 2016 Dec 22.
3
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.欧洲临床微生物学和传染病学会:艰难梭菌感染诊断指南文件的更新。
Clin Microbiol Infect. 2016 Aug;22 Suppl 4:S63-81. doi: 10.1016/j.cmi.2016.03.010. Epub 2016 Jul 25.
4
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.艰难梭菌感染:流行病学、诊断和传播途径的理解。
Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):206-16. doi: 10.1038/nrgastro.2016.25. Epub 2016 Mar 9.
5
Routine detection of Clostridium difficile in Western Australia.西澳大利亚艰难梭菌的常规检测
Anaerobe. 2016 Feb;37:34-7. doi: 10.1016/j.anaerobe.2015.11.007. Epub 2015 Nov 22.
6
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.非产毒艰难梭菌 M3 菌株孢子给药预防复发性艰难梭菌感染:一项随机临床试验。
JAMA. 2015 May 5;313(17):1719-27. doi: 10.1001/jama.2015.3725.
7
Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.在产毒艰难梭菌PCR核糖体分型027极低流行率的环境中,将BD MAX艰难梭菌检测法与Xpert艰难梭菌检测法进行性能评估。
Anaerobe. 2014 Dec;30:156-8. doi: 10.1016/j.anaerobe.2014.09.021. Epub 2014 Oct 7.
8
Epidemiology of Clostridium difficile infection in Asia.亚洲艰难梭菌感染的流行病学。
Antimicrob Resist Infect Control. 2013 Jul 1;2(1):21. doi: 10.1186/2047-2994-2-21.
9
Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Penisular Malaysia.马来西亚半岛东北部一家三级医院患者腹泻粪便样本中艰难梭菌毒素的流行情况。
Med J Malaysia. 2012 Aug;67(4):402-5.
10
Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines.菲律宾结肠炎患者中的艰难梭菌和溶组织内阿米巴感染。
Trans R Soc Trop Med Hyg. 2012 Jul;106(7):424-8. doi: 10.1016/j.trstmh.2012.04.005. Epub 2012 May 30.